Downtown Los Angeles, California
GOOD SAMARITAN HOSPITAL
Los Angeles, CA
Update on Diagnosis and Therapy
March 14, 2020
2019 CME SURVEYS, SPEAKER SLIDE DOWNLOAD & SYLLABUS
For access to CME surveys and symposium materials, use your registration email address to login. Surveys were due by May 6, 2019. Certificates are available online until January 1, 2020
IMPORTANT CME CREDIT NOTICE
CME Certificates will be issued digitally after Speaker and Symposium Surveys are completed online. Surveys are accessible after signing in with the email address you submitted during registration.
Surveys will be accessible online the day of the symposium and for 3 weeks following.
This Live activity, 24th Annual Heart Failure 2020: An Update on Therapy , with a beginning date of 03/14/2020 is currently being reviewed by an accrediting organization to determine credit hour awards.
This year’s program provides a comprehensive update on the prevention, diagnosis and management of heart failure (HF). The program includes lectures presented by experts combined with interactive discussion with faculty. The extensive list of topics has been selected to provide a high level, contemporary and clinically relevant update with a goal of improving the care of patients with heart failure.
At the conclusion of this activity, the participants should be able to:
- Implement effective therapy for lipid disorders
- Manage diabetes in patients with HF
- Use new FDA approved drugs for the treatment of chronic HF
- Identify new therapeutic approaches for patients with chronic HF including iron replacement
- Review effective management of the hospitalized patients with HF
- Review the clinical implications and management strategies of worsening kidney function during treatment of HF
- Assess and follow patients with HF using devices for remote hemodynamic monitoring
- Manage patients with pulmonary hypertension
- Review new information on atrial fibrillation ablation in patients with HF
- Provide an update on new biomarkers for the diagnosis and management of patients with HF
- Review mechanisms, diagnosis and management of postural tachycardia syndrome
- Select appropriate patients with severe HF due to ischemic cardiomyopathy for percutaneous and surgical revascularization
- Review results of recent trials and define indications for percutaneous mitral valve repair in patients with HF
- Review the mechanisms and hemodynamic effects of bed side circulatory assist devices for the management of severe HF and cardiogenic stroke
- Prove an update on new permanent left ventricular assist devices as a bridge to transplantation or as destination therapy
- Provide an update on the management of peripartum cardiomyopathy
- Provide guidelines for the use of palliative care for HF patients
This program has been designed to provide cardiologists, internists, primary care physicians, pharmacists, nurses and other healthcare providers with the necessary information to increase knowledge with the goal of improving the care of patients with HF.
It is our policy to ensure balance, independence, objectivity and scientific
rigor. All persons involved in the selection, development and presentation
of content are required to disclose any real or apparent conflicts of
interest. All conflicts of interest will be resolved prior to an educational
activity being delivered to learners through one of the following mechanisms
1) altering the financial relationship with the commercial interest, 2)
altering the individual’s control over CME content about the products
or services of the commercial interest, and/or 3) validating the activity
content through independent peer review. All persons are also required
to disclose any discussions of off label/unapproved uses of drugs or devices.
Persons who refuse or fail to disclose are disqualified from participating
in the CME activity. Participants will be asked to evaluate whether the
speaker’s outside interests reflect a possible bias in the planning
or presentation of the activity. This information is used to plan future